Your browser doesn't support javascript.
loading
Comparative Profiles of the WATCHMAN™ and Amplatzer™ Cardiac Plug/Amplatzer™ Amulet™ Devices for Left Atrial Appendage Closure in Non-valvular Atrial Fibrillation: A Comprehensive Systematic Review and Meta-analysis.
Raja, Fnu; Rani, Khimya; Kumar, Sunny; Someshwar, Fnu; Naseer Khan, Muhammad Ahsan; Abubakar, Fnu; Bhatt, Dhvani; Subedi, Deepak Jung; Shadmani, Sujeet; Zahra Abdullah, Fatima Tuz.
Affiliation
  • Raja F; Department of Internal Medicine, Federal Medical and Dental College, Islamabad, Pakistan.
  • Rani K; Department of Internal Medicine, Chandka Medical College SMBBMU, Larkana, Pakistan.
  • Kumar S; Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
  • Someshwar F; Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan.
  • Naseer Khan MA; Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan.
  • Abubakar F; Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan.
  • Bhatt D; Department of Internal Medicine, American University of Barbados, Bridgetown, Barbados.
  • Subedi DJ; Department of Internal Medicine, College of Medical Sciences, Bharatpur, Nepal.
  • Shadmani S; Department of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, Pakistan.
  • Zahra Abdullah FT; Department of Internal Medicine, Allama Iqbal Medical College, Lahore, Pakistan.
J Innov Card Rhythm Manag ; 15(6): 5917-5929, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38948665
ABSTRACT
Atrial fibrillation (AF) is a prevalent cardiac arrhythmia marked by irregular and frequent tachycardic rhythms in the atria, affecting 1%-2% of the general population. The WATCHMAN™ device from Boston Scientific (Marlborough, MA, USA) and the Amplatzer™ Amulet™ device from Abbott (Chicago, IL, USA) are two devices used globally for left atrial appendage closure (LAAC) in non-valvular AF. A systematic search was conducted in PubMed, the Cochrane Library, and Elsevier's ScienceDirect literature databases to identify studies comparing the WATCHMAN™ procedure with Amulet™ device implantation for LAAC in patients with AF. The analyses were conducted using the random-effects model. A total of 20 studies were identified, with 18 falling into the category of observational studies and 2 being randomized controlled trials. A total of 6310 participants were included in this meta-analysis, with 3198 individuals (50.68%) assigned to the WATCHMAN™ procedure group and 3112 individuals (49.32%) allocated to the Amplatzer™ Cardiac Plug (ACP) group. The analysis revealed a higher risk of stroke associated with the WATCHMAN™ technique (relative risk [RR], 1.14), albeit without statistical significance. Conversely, the WATCHMAN™ approach led to a significantly lower risk of cardiac death (RR, 0.44; P = .04). Notably, the risks of all-cause mortality (RR, 0.89; 95% confidence interval [CI], 0.73-1.08; I 2 = 0%; P = .25) and major bleeding (RR, 0.93; 95% CI, 0.65-1.33; I 2 = 31%; P = .70) were clinically reduced with the WATCHMAN™ procedure, although statistical significance was not achieved. Compared to Amulet™ device implantation, WATCHMAN™ device implantation decreased the risk of cardiac mortality, while the risks of stroke, systemic embolism, all-cause mortality, and major bleeding were not statistically significant.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Innov Card Rhythm Manag Year: 2024 Document type: Article Affiliation country: Pakistan

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Innov Card Rhythm Manag Year: 2024 Document type: Article Affiliation country: Pakistan